Search:
Login:
OR

Harlequin

Hybrid

(4.8 of 3 votes)
5

23.73%
1.25%
4.13%

About Harlequin


Harlequin is a 75/25 sativa-dominant hybrid that is popular for pain relief. This strain has been known to have particularly high levels of CBD making it a favorite of medical patients.


User Reviews


Written Reviews
Helpful?
up
down
9
Reviewed by: (3 reviews, Karma: 7) on September 22, 2013

Awesome pain med!

 
Taste
Potency
Aroma
Appearance
Helpful?
up
down
16
Reviewed by: (155 reviews, Karma: 456) on July 27, 2013

a great strain for daytime use when you need to tone down the pain and get things done.

 
Taste
Potency
Aroma
Appearance
Helpful?
up
down
18
Reviewed by: (4 reviews, Karma: 34) on September 26, 2012

This was the sweetist thing that has ever been in my vaporizer. The taste and aroma are amazing. Sweet, fresh and a bit green.
Good pain relief.
One note **there were some tiny seeds, they taste and smell like a huge dirt weed seed. I use a small hand grinder and the seeds jump out without destroying the bud.**
Worth every penny even at the high end.

 
Taste
Potency
Aroma
Appearance

Dispensaries Near You Carrying Harlequin


None yet


Recently Reviewed

Black Domina Black Domina
purple kush purple kush
Black Domina Black Domina
DARTH VADER DARTH VADER
FIRE OG FIRE OG


Top Rated

Hogs Breath Hogs Breath
King Louis IV OG King Louis IV OG
Cosmic OG Cosmic OG
WHITE RUSSIAN WHITE RUSSIAN
Platinum OG Platinum OG


Latest Offers In Your Area
Recent Blog Posts
Download Our App!
Therapeutic Health Center
28.9 Miles Away | Arlington, WA
Puget Sound Health Alternatives
4.9 Miles Away | Seattle, WA
Woodinville Alternative Medicine
15 Miles Away | Woodinville, WA
Maui Blue
April 16, 2014 | Category: Nugs
Study: Marijuana legalization doesn't increas
April 16, 2014 | Category: Legalization
We all know Spider man loves Mary Jane ; )
April 16, 2014 | Category: Fun
Mobile Apps
Copyright 2014 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us